Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
European Journal of Pharmacology
|
September 7, 2019
The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
Cheng-Tsung Liu, Li-Ting Kao, Jui-Hu Shih, et al.
Journal of Proteome Research
|
March 19, 2015
Proteomics analysis of EV71-infected cells reveals the involvement of host protein NEDD4L in EV71 replication
Rei-Lin Kuo, Ya-Han Lin, Robert Yung-Liang Wang, et al.
Antibiotics (Basel, Switzerland)
|
September 28, 2024
In Vivo Effect of Halicin on Methicillin-Resistant <i>Staphylococcus aureus</i>-Infected <i>Caenorhabditis elegans</i> and Its Clinical Potential
Li-Ting Kao, Tsung-Ying Yang, Wei-Chun Hung, et al.
Microorganisms
|
December 16, 2020
In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, et al.
Biomedicines
|
August 26, 2022
Anabolic Effects of a Novel Simvastatin Derivative on Treating Rat Bone Defects
Tien-Ching Lee, Hui-Ting Chen, I-Chun Tai, et al.
JCO Oncology Practice
|
December 9, 2025
Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes
Ren-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen, et al.
JCO Oncology Practice
|
May 6, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Po-Huang Chen, Hong-Jie Jhou, Wei-Cheng Chang, et al.
Frontiers in Pharmacology
|
November 4, 2021
Long-Term Use of Statins Lowering the Risk of Rehospitalization Caused by Ischemic Stroke Among Middle-Aged Hyperlipidemic Patients: A Population-Based Study
Jiu-Haw Yin, Giia-Sheun Peng, Kang-Hua Chen, et al.
Diabetology & Metabolic Syndrome
|
October 4, 2025
Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients
Ming-Hsun Lin, Ren-Hua Ye, Hong-Jie Jhou, et al.
Aging
|
June 3, 2022
Emergency SARS-CoV-2 variants of concern: rapidly direct RT-qPCR detection without RNA extraction, clinical comparison, cost-effective, and high-throughput
Bing-Heng Yang, Hsing-Yi Chung, Li-Ting Kao, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
European Journal of Pharmacology
|
September 7, 2019
The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
Cheng-Tsung Liu, Li-Ting Kao, Jui-Hu Shih, et al.
Journal of Proteome Research
|
March 19, 2015
Proteomics analysis of EV71-infected cells reveals the involvement of host protein NEDD4L in EV71 replication
Rei-Lin Kuo, Ya-Han Lin, Robert Yung-Liang Wang, et al.
Antibiotics (Basel, Switzerland)
|
September 28, 2024
In Vivo Effect of Halicin on Methicillin-Resistant <i>Staphylococcus aureus</i>-Infected <i>Caenorhabditis elegans</i> and Its Clinical Potential
Li-Ting Kao, Tsung-Ying Yang, Wei-Chun Hung, et al.
Microorganisms
|
December 16, 2020
In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, et al.
Biomedicines
|
August 26, 2022
Anabolic Effects of a Novel Simvastatin Derivative on Treating Rat Bone Defects
Tien-Ching Lee, Hui-Ting Chen, I-Chun Tai, et al.
JCO Oncology Practice
|
December 9, 2025
Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes
Ren-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen, et al.
JCO Oncology Practice
|
May 6, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Po-Huang Chen, Hong-Jie Jhou, Wei-Cheng Chang, et al.
Frontiers in Pharmacology
|
November 4, 2021
Long-Term Use of Statins Lowering the Risk of Rehospitalization Caused by Ischemic Stroke Among Middle-Aged Hyperlipidemic Patients: A Population-Based Study
Jiu-Haw Yin, Giia-Sheun Peng, Kang-Hua Chen, et al.
Diabetology & Metabolic Syndrome
|
October 4, 2025
Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients
Ming-Hsun Lin, Ren-Hua Ye, Hong-Jie Jhou, et al.
Aging
|
June 3, 2022
Emergency SARS-CoV-2 variants of concern: rapidly direct RT-qPCR detection without RNA extraction, clinical comparison, cost-effective, and high-throughput
Bing-Heng Yang, Hsing-Yi Chung, Li-Ting Kao, et al.
Page
of 14